KR20200001030A
|
|
Probe set for determining chromosomal aneuploidy of fetus and method for determining chromosomal aneuploidy of fetus using digital PCR
|
KR101789978B1
|
|
Electrode device for analyzing bio-material
|
KR20160100286A
|
|
Oligonucleotide for detecting Chlamydia trachomatis and/or Neisseria gonorrhoeae, and kit using the same
|
KR101732090B1
|
|
Method and system for providing diet information based on gene, and terminal using it
|
KR101721480B1
|
|
Method and system for detecting chromosomal abnormality
|
KR101683437B1
|
|
In-vitro diagnostic apparatus for bio-material
|
KR101642434B1
|
|
Apparatus including cartridge for in-vitro diagnostic bio-material
|
KR20160033054A
|
|
High Definition Probe for detecting human papilloma virus and kit using the same
|
KR101618032B1
|
|
Non-invasive detecting method for chromosal abnormality of fetus
|
KR20160098838A
|
|
Method and kit for NGS-based high efficiency, high resolution HLA typing
|
KR101632226B1
|
|
Method and agency server for providing agency service related to genome analysis service
|
KR20160083758A
|
|
Detection of mutations in ATP7B gene using PCR-LDR
|
KR20160069867A
|
|
Oligonucleotide for detecting Chlamydia trachomatis and/or Neisseria gonorrhoeae, and kit using the same
|
KR20160051083A
|
|
High Definition Probe for detecting microorganism causing sexually transmitted disease and kit using the same
|
KR20150025281A
|
|
Detection of gene of interest based on electrochemical real-time PCR and device therefor
|
KR20130100075A
|
|
Brca2 germline mutations useful for predicting genetic predisposition of breast cancer or ovarian cancer
|
KR20140140386A
|
|
Detection of mutations in ATP7B gene using Real-Time PCR
|
KR20130057760A
|
|
Brca1 and brca2 germline mutations useful for predicting genetic predisposition of breast cancer or ovarian cancer
|
WO2011145764A1
|
|
Microorganism for quantifying homocysteine, and use thereof
|
KR20110128056A
|
|
Microorganism for quantifying homocysteine and use thereof
|